Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Sep 20;3(1):160-167.
doi: 10.1016/j.ekir.2017.09.005. eCollection 2018 Jan.

Trimethoprim+Sulfamethoxazole Reduces Rates of Melioidosis in High-Risk Hemodialysis Patients

Affiliations

Trimethoprim+Sulfamethoxazole Reduces Rates of Melioidosis in High-Risk Hemodialysis Patients

Sandawana William Majoni et al. Kidney Int Rep. .

Abstract

Introduction: Melioidosis causes sepsis and death in the Top End of Northern Australia during the monsoonal wet season. Dialysis-dependent adults suffer higher melioidosis rates compared to low rates among renal transplant patients who routinely receive trimethoprim+sulfamethoxazole prophylaxis.

Methods: We performed a prospective interventional study to determine the efficacy and safety of daily trimethoprim+sulfamethoxazole prophylaxis in hemodialysis patients during the wet season, from 1 November 2014 to 30 April 2015. Hemodialysis (for ≥ 3 months) patients ≥ 18 years of age were offered treatment. A total of 269 patients on hemodialysis were eligible. Eight of the 269 patients (3%) were excluded from the analysis for being on melioidosis treatment. In all, 169 of 261 patients (64.8%) received the prophylaxis, and 92 of 261 patients (35.2%) did not, because of allergy history (n = 10), remoteness and logistical reasons (n = 60), poor dialysis attendance (n = 11), and refusal (n = 11). We monitored for clinical side effects 3 times weekly and neutropenia, thrombocytopenia, and liver function monthly throughout treatment and for 2 months posttreatment.

Results: In all, 169 of 261 patients (64.8%) received the prophylaxis. There was no age (years) difference by group (prophylaxis vs. nonprophylaxis, 54.7 [11.3] vs. 54.3 [11.2] [P = 0.751]). Sixteen of 261 patients (6%) had melioidosis. The event frequency was 0% (0/169, prophylaxis, vs. 17.4% [16/92, nonprophylaxis], P < 0.001). Higher thrombocytopenia and neutropenia rates were noted in the prophylaxis group. These did not warrant treatment stoppage. There was no difference in liver function. Three patients (1.8%) withdrew from the treatment because of side effects.

Conclusion: Daily dosing was effective and safe. Posthemodialysis dosing in the subsequent seasons was effective and safer. We recommend this approach in melioidosis-prevalent regions.

Keywords: hemodialysis; melioidosis; northern Australia; sepsis; trimethoprim+sulfamethoxazole; wet season.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Correlation between cases of melioidosis managed at Royal Darwin Hospital in 2009–2010 and rainfall at Darwin airport.
Figure 2
Figure 2
Melioidosis intervention study flow diagram.

References

    1. Wiersinga W.J., Currie B.J., Peacock S.J. Melioidosis. N Engl J Med. 2012;367:1035–1044. - PubMed
    1. Stephens D.P., Thomas J.H., Ward L.M. Melioidosis causing critical illness: a review of 24 years of experience from the Royal Darwin Hospital ICU. Crit Care Med. 2016;44:1500–1505. - PubMed
    1. Australian Bureau of Meteorology. Australian Bureau of Meteorology. (2017) Monthly Rainfall Climate Data, Darwin Airport. Australian Government [17 March 2017]. Available at: http://www.bom.gov.au/climate/data/. Accessed August 13, 2017.
    1. Limmathurotsakul D., Golding N., Dance D.A. Predicted global distribution of Burkholderia pseudomallei and burden of melioidosis. Nat Microbiol. 2016;1 - PubMed
    1. Currie B.J., Kestli M. Epidemiology: a global picture of melioidosis. Nature. 2016;529:290–291. - PubMed

LinkOut - more resources